Patheon to Exhibit at Contract Manufacturing Conference in June


Patheon, one of the leading global providers of contract dosage form development and manufacturing services to the pharmaceutical and biotechnology industries has just announced they will be exhibiting at Pharma IQ’s Global Pharmaceutical Contract Manufacturing conference this June in London.

Patheon’s development and manufacturing capabilities cover prescription (Rx) products in solid, semi-solid and liquid dosage forms, as well as specialized capabilities in high-potency, cephalosporin, controlled/sustained release and sterile manufacturing, including aseptic filling and lyophilization.

Their Pharmaceutical Development Services (PDS) group offers contract pre-formulation, formulation and analytical development, clinical trial materials (CTM) manufacturing, clinical packaging and scale-up services for pharmaceutical products of essentially all types, including biopharmaceuticals.

With over 4,000 highly-skilled staff, Patheon’s network of modern manufacturing facilities located in the United States, Canada, Italy, France and the United Kingdom Patheon well equipped to meet the international requirements of its customers.

Nichola Welch, Conference director at Pharma IQ responded to the announcement saying “This is great opportunity for our delegates to interact directly with Patheon and explore their solutions in a productive environment. Not only will it make for interesting and varied discussion, Patheon will certainly help support the event’s aim to allow participants to take home essential practical advice and guidance from industry leaders.”

Speakers at the conference include Joaquin Santos, GPSG, Senior Director External Manufacturing; EMEA Region, Johnson and Johnson, Béatrice Serckx-Poncin, Associate Director, Drug Product Industrial Strategy and CMO management, UCB, Kim Steffensen, Department Head Contract Manufacturing & Licensing, Novo Nordisk , Richard Fazackley, Associate Director, Product Realisation, Eisai , Dr Ulrich Rumenapp, Head Biotech Projects, Bayer Schering Healthcare AG  and Jim Browne, Director, Contract Manufacturing, Europe, GlaxoSmithKline.

The Global Pharmaceutical Contract Manufacturing conference, now in its third year returns with an expanded view now encompassing the entire international contract manufacturing landscape. The event will deliver the opportunity to hear first hand experience of outsourced manufacturing from both the pharmaceutical and CMO viewpoint. The event is valuable opportunity to discuss and network with key professionals from both sides of the coin through tailored presentation, group discussion and networking sessions.


Editors Notes.

IQPC has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries’ trends, technological developments and regulatory landscape. For any more information please contact: Nichola Welch, +44 (0)20 7368 9300